AR070395A1 - Derivados de 4,5-dihidro-oxazol-2-il- amina - Google Patents
Derivados de 4,5-dihidro-oxazol-2-il- aminaInfo
- Publication number
- AR070395A1 AR070395A1 ARP090100540A ARP090100540A AR070395A1 AR 070395 A1 AR070395 A1 AR 070395A1 AR P090100540 A ARP090100540 A AR P090100540A AR P090100540 A ARP090100540 A AR P090100540A AR 070395 A1 AR070395 A1 AR 070395A1
- Authority
- AR
- Argentina
- Prior art keywords
- lower alkyl
- halogen
- hydrogen
- lower alkoxy
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/28—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
La presente se refiere a compuestos de la formula (1) en la que R1/R1' con independencia entre sí son hidrogeno, halogeno, alcoxi inferior, alquilo inferior, alquilo inferior sustituido por halogeno, alcoxi inferior sustituido por halogeno, alcoxi inferior sustituido por hidroxi, - O-(CH2)o-O-alquilo inferior, -(CH2)p-O-alquilo inferior, -O-S(O)2-alquilo inferior, -S(O)2-aIquilo inferior o ciano; o R1 y R1' junto con -(CH2)2O-, -O-CH2-O- o -N(R)-(CH2)2-O- pueden formar un anillo de 5 o 6 eslabones junto con los átomos de carbono a los que están unidos; R es hidrogeno o alquilo inferior; R2 es hidrogeno, halogeno, alquilo inferior, ciano, alcoxi inferior, alcoxi inferior sustituido por halogeno, -O-(CH2)p-cicIoalquilo C3-6 o (CH2)o-O-alquilo inferior; R3 con independencia entre sí son hidrogeno, ciano, alcoxi inferior, alquilo inferior, alquilo inferior sustituido por halogeno, alcoxi inferior sustituido por halogeno, -CH2-O-alquilo inferior, -C(O)N-dialquilo inferior o halogeno; R4 es hidrogeno o alquilo inferior; X es un enlace, -NH-C(O)-, -NH- o -O-CH2; Ar es arilo o heteroarilo; y en la que -X-Ar-(R3)m ocupa la posicion 3 o 4 del anillo fenilo; o X-Ar-(R3)m significa benzo[1,3]dioxol; m es el numero 0, 1 o 2; o es el numero 2 o 3; p es el numero 1, 2 o 3; o las sales de adicion de ácido farmacéuticamente activas de los mismos. Se ha encontrado que los compuestos presentes tienen actividad inhibidora de la Asp2 (beta- secretasa, BACE 1 o memapsina-2) y por ello estos compuestos pueden utilizarse para el tratamiento de enfermedades caracterizadas por niveles elevados de amiloide beta o depositos de amiloide beta, en particular la enfermedad de Alzheimer. Procesos de obtencion y composiciones farmacéuticas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08151546 | 2008-02-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR070395A1 true AR070395A1 (es) | 2010-03-31 |
Family
ID=40545768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090100540A AR070395A1 (es) | 2008-02-18 | 2009-02-16 | Derivados de 4,5-dihidro-oxazol-2-il- amina |
Country Status (16)
Country | Link |
---|---|
US (1) | US7989449B2 (es) |
EP (1) | EP2245019B1 (es) |
JP (1) | JP5258904B2 (es) |
KR (1) | KR101259240B1 (es) |
CN (1) | CN101952260B (es) |
AR (1) | AR070395A1 (es) |
AU (1) | AU2009216825A1 (es) |
BR (1) | BRPI0907563A2 (es) |
CA (1) | CA2712228C (es) |
CL (1) | CL2009000349A1 (es) |
ES (1) | ES2398017T3 (es) |
IL (1) | IL206765A0 (es) |
MX (1) | MX2010008347A (es) |
PE (1) | PE20091466A1 (es) |
TW (1) | TW200938537A (es) |
WO (1) | WO2009103626A1 (es) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7700603B2 (en) * | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
US7763609B2 (en) * | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
AR054617A1 (es) * | 2005-06-14 | 2007-07-04 | Schering Corp | Derivados de pirrol[3, 4 - d]pirimidina como inhibidores de aspartil proteasas y composiciones farmacéuticas que los comprenden |
EP1896032B1 (en) * | 2005-06-14 | 2012-10-31 | Merck Sharp & Dohme Corp. | The preparation and use of compounds as protease inhibitors |
ES2572263T3 (es) | 2005-10-25 | 2016-05-31 | Shionogi & Co | Derivados de dihidrooxazina y tetrahidropirimidina como inhibidores de BACE 1 |
EP2032542A2 (en) | 2006-06-12 | 2009-03-11 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
ES2476605T3 (es) | 2007-04-24 | 2014-07-15 | Shionogi & Co., Ltd. | Derivados de aminohidrotiazina sustituidos con grupos cíclicos |
JP5383483B2 (ja) | 2007-04-24 | 2014-01-08 | 塩野義製薬株式会社 | アルツハイマー症治療用医薬組成物 |
AU2009239536C1 (en) * | 2008-04-22 | 2012-12-13 | Merck Sharp & Dohme Corp. | Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use |
CN102119161B (zh) | 2008-06-13 | 2015-07-08 | 盐野义制药株式会社 | 具有β分泌酶抑制作用的含硫杂环衍生物 |
EP2324032B1 (en) * | 2008-08-19 | 2014-10-01 | Vitae Pharmaceuticals, Inc. | Inhibitors of beta-secretase |
MY148558A (en) * | 2008-09-11 | 2013-04-30 | Amgen Inc | Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use |
EP2360155A4 (en) | 2008-10-22 | 2012-06-20 | Shionogi & Co | 2-AMINOPYRIDIN-4-ON AND 2-AMINOPYRIDINE DERIVATIVE WITH BACE1-HEMDERING EFFECT |
AR075854A1 (es) * | 2009-03-13 | 2011-05-04 | Vitae Pharmaceuticals Inc | Inhibidores de beta- secretasa |
US20110065695A1 (en) * | 2009-09-11 | 2011-03-17 | Jeremy Beauchamp | Use of aminodihydrothiazines for the treatment or prevention of diabetes |
UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
US8354441B2 (en) * | 2009-11-11 | 2013-01-15 | Hoffmann-La Roche Inc. | Oxazoline derivatives |
WO2011070781A1 (ja) | 2009-12-09 | 2011-06-16 | 塩野義製薬株式会社 | 置換アミノチアジン誘導体 |
UA103272C2 (uk) * | 2009-12-11 | 2013-09-25 | Ф. Хоффманн-Ля Рош Аг | 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2 |
UA110467C2 (uk) | 2009-12-11 | 2016-01-12 | Шионогі Енд Ко., Лтд. | Похідні оксазину |
JPWO2011077726A1 (ja) | 2009-12-24 | 2013-05-02 | 塩野義製薬株式会社 | 4−アミノ−1,3−チアジンまたはオキサジン誘導体 |
EP2539322B1 (en) | 2010-02-24 | 2014-01-01 | Vitae Pharmaceuticals, Inc. | Inhibitors of beta-secretase |
MX2012010657A (es) | 2010-03-15 | 2013-02-07 | Amgen Inc | Compuestos de espiro amino-dihidrooxazina y amino-dihidrotiazina como moduladores de beta-secretasa y su uso medico. |
CA2791281A1 (en) | 2010-03-15 | 2011-09-22 | Amgen Inc. | Spiro-tetracyclic ring compounds as beta-secretase modulators |
US8815881B2 (en) * | 2010-08-09 | 2014-08-26 | Hoffmann-La Roche Inc. | 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds |
US9018219B2 (en) | 2010-10-29 | 2015-04-28 | Shionogi & Co., Ltd. | Fused aminodihydropyrimidine derivative |
WO2012057248A1 (ja) | 2010-10-29 | 2012-05-03 | 塩野義製薬株式会社 | ナフチリジン誘導体 |
PL2663561T3 (pl) * | 2011-01-13 | 2016-10-31 | Nowe pochodne heterocykliczne i ich zastosowanie w leczeniu zaburzeń neurologicznych | |
US8399459B2 (en) | 2011-02-02 | 2013-03-19 | Hoffmann-La Roche Inc. | 1,4 oxazines as BACE1 and/or BACE2 inhibitors |
US9346827B2 (en) | 2011-02-07 | 2016-05-24 | Amgen Inc. | 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use |
TW201247635A (en) | 2011-04-26 | 2012-12-01 | Shionogi & Co | Oxazine derivatives and a pharmaceutical composition for inhibiting BAC1 containing them |
EP2758406A1 (en) | 2011-09-21 | 2014-07-30 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
DE102011055815A1 (de) | 2011-11-29 | 2013-05-29 | Aicuris Gmbh & Co. Kg | Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung |
TWI557112B (zh) | 2012-03-05 | 2016-11-11 | 百靈佳殷格翰國際股份有限公司 | β-分泌酶抑制劑 |
DE102012016908A1 (de) | 2012-08-17 | 2014-02-20 | Aicuris Gmbh & Co. Kg | Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung |
TW201422592A (zh) | 2012-08-27 | 2014-06-16 | Boehringer Ingelheim Int | β-分泌酶抑制劑 |
US9290477B2 (en) | 2012-09-28 | 2016-03-22 | Vitae Pharmaceuticals, Inc. | Inhibitors of β-secretase |
EP2912035A4 (en) | 2012-10-24 | 2016-06-15 | Shionogi & Co | DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY |
US9725469B2 (en) | 2012-11-15 | 2017-08-08 | Amgen, Inc. | Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
WO2016055496A1 (en) * | 2014-10-10 | 2016-04-14 | F. Hoffmann-La Roche Ag | Bace1 inhibitors |
JP6674960B2 (ja) | 2015-03-20 | 2020-04-01 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Bace1阻害剤 |
EP3463359A4 (en) * | 2016-06-02 | 2020-08-26 | Purdue Pharma LP | SPURENAMINE-ASSOCIATED RECEPTOR-1 AGONISTS AND PARTIAL AGONISTS FOR PAIN MANAGEMENT |
CN113729026A (zh) * | 2021-10-09 | 2021-12-03 | 合肥巨卓农业技术开发有限公司 | 一种包含啶磺草胺和异丙隆的复合除草剂 |
TW202342013A (zh) * | 2022-02-10 | 2023-11-01 | 英屬開曼群島商百濟神州有限公司 | 雜環化合物、其組成物及用其進行治療之方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK302185A (da) * | 1984-07-05 | 1986-01-06 | Rolland Sa A | 2-amino-oxazoliner samt fremgangsmaade til deres fremstilling |
TW200602045A (en) * | 2004-06-16 | 2006-01-16 | Wyeth Corp | Amino-5, 5-diphenylimidazolone derivatives for the inhibition of β-secretase |
CN101360716A (zh) * | 2005-11-21 | 2009-02-04 | 阿斯利康(瑞典)有限公司 | 新颖的2-氨基-咪唑-4-酮化合物及其在制备用于治疗认知缺损、阿尔茨海默病、神经变性和痴呆的药物中的用途 |
TW200734311A (en) * | 2005-11-21 | 2007-09-16 | Astrazeneca Ab | New compounds |
EP2114906B1 (en) * | 2007-02-02 | 2014-08-06 | F. Hoffmann-La Roche AG | 2-aminooxazolines as taar1 ligands for cns disorders |
-
2009
- 2009-02-09 MX MX2010008347A patent/MX2010008347A/es active IP Right Grant
- 2009-02-09 BR BRPI0907563-1A patent/BRPI0907563A2/pt not_active IP Right Cessation
- 2009-02-09 ES ES09711573T patent/ES2398017T3/es active Active
- 2009-02-09 WO PCT/EP2009/051452 patent/WO2009103626A1/en active Application Filing
- 2009-02-09 CN CN2009801052316A patent/CN101952260B/zh not_active Expired - Fee Related
- 2009-02-09 JP JP2010547144A patent/JP5258904B2/ja not_active Expired - Fee Related
- 2009-02-09 KR KR1020107018239A patent/KR101259240B1/ko not_active IP Right Cessation
- 2009-02-09 CA CA2712228A patent/CA2712228C/en not_active Expired - Fee Related
- 2009-02-09 EP EP09711573A patent/EP2245019B1/en not_active Not-in-force
- 2009-02-09 AU AU2009216825A patent/AU2009216825A1/en not_active Abandoned
- 2009-02-12 US US12/369,782 patent/US7989449B2/en not_active Expired - Fee Related
- 2009-02-16 AR ARP090100540A patent/AR070395A1/es unknown
- 2009-02-16 TW TW098104870A patent/TW200938537A/zh unknown
- 2009-02-16 PE PE2009000228A patent/PE20091466A1/es not_active Application Discontinuation
- 2009-02-16 CL CL2009000349A patent/CL2009000349A1/es unknown
-
2010
- 2010-07-01 IL IL206765A patent/IL206765A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2712228A1 (en) | 2009-08-27 |
JP2011512378A (ja) | 2011-04-21 |
KR20100130595A (ko) | 2010-12-13 |
PE20091466A1 (es) | 2009-09-24 |
AU2009216825A1 (en) | 2009-08-27 |
ES2398017T3 (es) | 2013-03-13 |
WO2009103626A1 (en) | 2009-08-27 |
CN101952260A (zh) | 2011-01-19 |
CN101952260B (zh) | 2013-02-13 |
CA2712228C (en) | 2013-04-16 |
MX2010008347A (es) | 2010-11-12 |
US20090209529A1 (en) | 2009-08-20 |
US7989449B2 (en) | 2011-08-02 |
JP5258904B2 (ja) | 2013-08-07 |
IL206765A0 (en) | 2010-12-30 |
EP2245019B1 (en) | 2012-11-14 |
BRPI0907563A2 (pt) | 2015-08-04 |
TW200938537A (en) | 2009-09-16 |
CL2009000349A1 (es) | 2010-02-19 |
KR101259240B1 (ko) | 2013-04-29 |
EP2245019A1 (en) | 2010-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR070395A1 (es) | Derivados de 4,5-dihidro-oxazol-2-il- amina | |
AR054560A1 (es) | Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
MX2015015893A (es) | 2-fenilimidazo[1,2-a]pirimidinas como agentes formadores de imagen. | |
PE20151375A1 (es) | Compuestos ciclicos eter pirazol-4-il-heterociclil-carboxamida y metodos de utilizacion | |
AR072952A1 (es) | Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso | |
EA201071370A1 (ru) | Серосодержащее гетероциклическое производное, обладающее активностью ингибитора бета-секретазы | |
AR066509A1 (es) | Derivados de tiazol, medicamentos que los contienen, proceso de preparacion y usos como moduladores de beta amiloide. | |
CU20110217A7 (es) | Derivados amino-propiónicos sustituidos como inhibidores de neprilisina | |
GT201300179A (es) | Derivados heterociclicos novedosos y su uso en el tratamiento de trastornos neurologicos | |
CR20120002A (es) | Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos | |
CO6670589A2 (es) | Compuestos para reducir la producción de beta-amiloide | |
CO6612267A2 (es) | Nuevos derivados de 1,1 dióxido- 5 fenil- 2,3,4-5tetrahidro- 1,4-benzotiazepina y composiciones farmaceúticas que los comprenden | |
AR049647A1 (es) | Cis-imidazolinas | |
EA200970510A1 (ru) | Гетеромоноциклическое соединение и его применение | |
AR079327A1 (es) | Derivados de 2-amino-5,5-difluor -5,6-dihidro-4h-(1,3) oxazin-4-il) fenil)-amida | |
AR077977A1 (es) | Compuestos y composiciones como inhibidores de cinasa de proteina | |
AR087915A1 (es) | N-(3-(2-amino-6,6-difluor-4,4a,5,6,7,7a-hexahidro-ciclopenta-[e][1,3]oxazin-4-il)-fenil)-amidas como inhibidores de la bace1 | |
AR084011A1 (es) | Compuestos nitrogenados heterociclicos utiles para el tratamiento de infecciones por el virus sincitial respiratorio (rsv), proceso para prepararlos y composiciones farmaceuticas que los contienen | |
AR066020A1 (es) | Derivados de imidazolidin-2, 4-diona, una composicion farmaceutica que los comprende y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de parp-1. | |
ECSP11010804A (es) | Compuestos orgánicos | |
AR084976A1 (es) | Compuestos de bifenileno sustituidos y metodos de uso de los mismos para el tratamiento de enfermedades virales | |
AR078321A1 (es) | Derivados de 2,4'-bipiridina como inhibidores de cinasa (cdk9) | |
PE20141380A1 (es) | Imidazopiridazinas como inhibidores de quinasa akt | |
PE20151892A1 (es) | Compuestos tetraciclicos sustituidos con heterociclo y metodos de uso de los mismos para el tratamiento de enfermedades viricas | |
AR065464A1 (es) | Derivados de nicotinamida. composiciones farmaceuticas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |